IBA Launched QUASAR Penta-Guide Performance Phantom
The new device enables integrated quality assurance for radiotherapy by consolidating over 25 testing procedures.
Updated on Sept. 27, 2026 in Quantum Computing
Live Poll
Do you believe new medical diagnostic tools generally improve patient access to high-quality care?
IBA has launched the QUASAR Penta-Guide Performance Phantom, a device designed to perform more than 25 imaging and machine quality assurance (QA) tests in a single setup. The system includes integrated software for automated data analysis and DICOM (Digital Imaging and Communications in Medicine) file management.
Why it matters
By consolidating multiple procedures into one workflow, the device aims to minimize procedural variability and reduce the setup time required in complex image-guided and adaptive radiotherapy environments. This consolidation addresses the need for greater efficiency in clinical quality assurance.
The system supports both 2D and 3D imaging tests within a single platform. It utilizes integrated software to automate data analysis and report generation, which replaces the manual entry or multi-tool processes typically required for verifying equipment accuracy.
The players
IBA
Headquartered in Louvain-la-Neuve, Belgium, this medical technology firm employs 2,300 people and specializes in proton therapy solutions and radiotherapy quality assurance equipment.
The details
The phantom functions as a standardized reference object used to verify the output and image quality of radiotherapy equipment. By integrating DICOM handling—the international standard for transmitting and managing medical images and data—the system automates the analysis pipeline to ensure consistency across radiotherapy workflows. This automation reduces the manual interventions that often introduce error or inconsistency during routine quality assurance checks.
Timeline
September 27, 2026: The QUASAR Penta-Guide Performance Phantom was officially launched.
The Tech Race
This development represents a shift in the radiotherapy quality assurance field toward all-in-one hardware solutions. It follows a broader trend in medical engineering that seeks to replace disparate verification tools with unified diagnostic phantom platforms.
Clinicians and medical physicists in radiotherapy departments will be the primary users, as the device simplifies the daily calibration and verification required for adaptive treatment planning. Facilities can expect to integrate the phantom into existing 2D and 3D imaging workflows to standardize reporting.
The takeaway
The move toward single-setup QA reflects the industry's focus on reducing the operational burden of high-precision radiotherapy. Watch for future integration updates that may further automate the hand-off between imaging data and machine adjustment software.
Further reading
For more on the evolution of automated diagnostic systems and equipment testing, see Quantum Computing.
More information
For additional specifications and product details, visit the IBA company information website.
Live Poll
Do you believe new medical diagnostic tools generally improve patient access to high-quality care?
